Literature DB >> 19342071

Impact of a single amino acid in the variable region 2 of the Old World monkey TRIM5alpha SPRY (B30.2) domain on anti-human immunodeficiency virus type 2 activity.

Ken Kono1, Katarzyna Bozek, Francisco S Domingues, Tatsuo Shioda, Emi E Nakayama.   

Abstract

Variable region 1 (V1) of the SPRY domain of TRIM5alpha is a major determinant for species-specific virus restriction in primates. We previously reported that a chimeric TRIM5alpha containing baboon V1 in the background of cynomolgus monkey TRIM5alpha showed potent anti-human immunodeficiency virus type 2 (HIV-2) activity. Since baboons are reportedly sensitive to HIV-2 infection, there was a discrepancy between the ability of baboon TRIM5alpha V1 to restrict HIV-2 and baboon sensitivity to HIV-2. In the study presented here, we examined the roles of V2 and V3 of the baboon TRIM5alpha SPRY domain in its anti-HIV-2 activity. A chimeric TRIM5alpha containing the entire baboon SPRY domain showed weak anti-HIV-2 activity. This attenuation of activity was caused by a single serine-to-proline substitution in baboon TRIM5alpha V2. These findings indicate that the combination of V1 with other variable regions of SPRY is important in anti-HIV-2 activity of primate TRIM5alpha.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19342071     DOI: 10.1016/j.virol.2009.03.004

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  9 in total

Review 1.  Structure and function of the SPRY/B30.2 domain proteins involved in innate immunity.

Authors:  Akshay A D'Cruz; Jeffrey J Babon; Raymond S Norton; Nicos A Nicola; Sandra E Nicholson
Journal:  Protein Sci       Date:  2013-01       Impact factor: 6.725

2.  Multiple sites in the N-terminal half of simian immunodeficiency virus capsid protein contribute to evasion from rhesus monkey TRIM5α-mediated restriction.

Authors:  Ken Kono; Haihan Song; Masaru Yokoyama; Hironori Sato; Tatsuo Shioda; Emi E Nakayama
Journal:  Retrovirology       Date:  2010-09-08       Impact factor: 4.602

3.  A single amino acid of human immunodeficiency virus type 2 capsid protein affects conformation of two external loops and viral sensitivity to TRIM5α.

Authors:  Tadashi Miyamoto; Masaru Yokoyama; Ken Kono; Tatsuo Shioda; Hironori Sato; Emi E Nakayama
Journal:  PLoS One       Date:  2011-07-28       Impact factor: 3.240

4.  Characterization of a core fragment of the rhesus monkey TRIM5α protein.

Authors:  Alak K Kar; Youdong Mao; Gregory Bird; Loren Walensky; Joseph Sodroski
Journal:  BMC Biochem       Date:  2011-01-04       Impact factor: 4.059

5.  TRIM5α and Species Tropism of HIV/SIV.

Authors:  Emi E Nakayama; Tatsuo Shioda
Journal:  Front Microbiol       Date:  2012-01-24       Impact factor: 5.640

6.  Evolutionary and Functional Analysis of Old World Primate TRIM5 Reveals the Ancient Emergence of Primate Lentiviruses and Convergent Evolution Targeting a Conserved Capsid Interface.

Authors:  Kevin R McCarthy; Andrea Kirmaier; Patrick Autissier; Welkin E Johnson
Journal:  PLoS Pathog       Date:  2015-08-20       Impact factor: 6.823

Review 7.  Impact of TRIM5α in vivo.

Authors:  Emi E Nakayama; Tatsuo Shioda
Journal:  AIDS       Date:  2015-09-10       Impact factor: 4.177

8.  In silico analysis of functional single nucleotide polymorphisms in the human TRIM22 gene.

Authors:  Jenna N Kelly; Stephen D Barr
Journal:  PLoS One       Date:  2014-07-01       Impact factor: 3.240

9.  Trafficking of some old world primate TRIM5α proteins through the nucleus.

Authors:  Felipe Diaz-Griffero; Daniel E Gallo; Thomas J Hope; Joseph Sodroski
Journal:  Retrovirology       Date:  2011-05-15       Impact factor: 4.602

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.